Novazyme Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Novazyme Pharmaceuticals?

Novazyme Pharmaceuticals is funded by Aisling Capital.

Q: How much funding has Novazyme Pharmaceuticals raised to date?

Novazyme Pharmaceuticals has raised obfuscated.

Overview

Novazyme Pharmaceuticals

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Novazyme Pharmaceuticals

Novazyme Pharmaceuticals is a biotech startup that conducts research on a new experimental treatment for Pompe disease.

Closed

Private

Series B

Oklahoma City, Oklahoma, United States

Biotechnology

Pharmaceutical

Therapeutics

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

John Crowley: CEO and Founder
Past Role: Amicus Therapeutics, Executive Chairman & Founder

Details

Legal Name

Novazyme Pharmaceuticals, Inc.

Operating Status

Closed

Company Type

For Profit

Founders

John Crowley

About the Company

Novazyme Pharmaceuticals is a biotech startup that conducts research on a new experimental treatment for Pompe disease.

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Novazyme Pharmaceuticals	—	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Aisling Capital	—	Series A - Novazyme Pharmaceuticals	—
Aisling Capital	—	Series A - Novazyme Pharmaceuticals	—
Aisling Capital	—	Series A - Novazyme Pharmaceuticals	—
Aisling Capital	—	Series A - Novazyme Pharmaceuticals	—
Aisling Capital	—	Series A - Novazyme Pharmaceuticals	—